Szpalski Marek, Gunzburg Robert, Sztern Bernard
Department of Orthopedic Surgery, IRIS South Teaching Hospitals, 142 rue Marconi, 1190 Brussels, Belgium.
Eur Spine J. 2004 Oct;13 Suppl 1(Suppl 1):S18-27. doi: 10.1007/s00586-004-0752-y. Epub 2004 Jun 15.
The problems linked to blood loss and blood-sparing techniques in spine surgery have been less studied than in other fields of orthopedics, such as joint-replacement procedures. Decreasing bleeding is not only important for keeping the patient's hemodynamic equilibrium but also for allowing a better view of the surgical field. In spine surgery the latter aspect is especially important because of the vicinity of major and highly fragile neurologic structures. The techniques and agents used for hemostasis and blood sparing in spinal procedures are mostly similar to those used elsewhere in surgery. Their use is modulated by the specific aspects of spinal approach and its relation to the contents of the spinal canal. Blood-sparing techniques can be divided into two categories based on their goals: either they are aimed at decreasing the bleeding itself, or they are aimed at decreasing the need for homologous transfusion. Various hemodynamic techniques, as well as systemic and local drugs and agents, can be used separately or in combination, and their use in the field of spine surgery is reported. The level of evidence for the efficacy of many of those methods in surgery as a whole is limited, and there is a lack of evidence for most of them in spine surgery. However, several blood-saving procedures and drugs, as well as promising new agents, appear to be efficient, although their efficacy has yet to be assessed by proper randomized controlled trials.
与脊柱手术中失血和血液保护技术相关的问题,相较于其他骨科领域(如关节置换手术),受到的研究较少。减少出血不仅对维持患者的血流动力学平衡很重要,而且对于获得更好的手术视野也很重要。在脊柱手术中,后一个方面尤为重要,因为主要且高度脆弱的神经结构位置临近。脊柱手术中用于止血和血液保护的技术及药物,大多与手术其他部位使用的类似。其使用会根据脊柱手术入路的具体情况及其与椎管内容物的关系进行调整。血液保护技术根据其目标可分为两类:要么旨在减少出血本身,要么旨在减少异体输血的需求。各种血流动力学技术以及全身和局部药物及制剂可单独或联合使用,本文报道了它们在脊柱手术领域的应用情况。这些方法中许多在整个外科手术中的疗效证据水平有限,而在脊柱手术中大多数方法缺乏证据。然而,一些血液保存程序和药物以及有前景的新制剂似乎是有效的,尽管它们的疗效尚未通过适当的随机对照试验进行评估。